We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current POAI market cap is 6.52M. The company's latest EPS is USD -3.4417 and P/E is -0.44.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 456k | 363k | 240k | 490k | 715k |
Operating Income | -4.13M | -7.97M | -3.47M | -3.96M | -3.15M |
Net Income | -4.06M | -7.92M | -3.42M | -3.92M | -3.16M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.41M | 1.25M | 1.42M | 1.51M | 1.78M |
Operating Income | -16.92M | -25.36M | -20.43M | -26.04M | -14.08M |
Net Income | -19.68M | -26.44M | -19.66M | -25.74M | -13.98M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 33.17M | 25.74M | 25.06M | 20.97M | 18.17M |
Total Liabilities | 3.57M | 3.97M | 6.51M | 6.26M | 6.52M |
Total Equity | 29.59M | 21.77M | 18.55M | 14.71M | 11.65M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 22.38M | 13.06M | 43.77M | 25.74M | 14.42M |
Total Liabilities | 11.15M | 10.42M | 3.51M | 3.97M | 6.15M |
Total Equity | 11.23M | 2.64M | 40.27M | 21.77M | 8.27M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -9.14M | -12.37M | -3.43M | -7M | -10.11M |
Investing | -412k | -476k | -47k | -306k | -310k |
Financing | 6.74M | 6.72M | N/A | N/A | 260k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.73M | -12.26M | -12.21M | -12.37M | -13.19M |
Investing | -599k | -167k | -10.61M | -476k | -302k |
Financing | 9.32M | 12.95M | 50.34M | 6.72M | 148k |
Market Cap | 6.52M |
Price to Earnings Ratio | -0.44 |
Price to Sales Ratio | 3.45 |
Price to Cash Ratio | 0.7 |
Price to Book Ratio | 0.74 |
Dividend Yield | - |
Shares Outstanding | 4.06M |
Average Volume (1 week) | 112.04k |
Average Volume (1 Month) | 54.7k |
52 Week Change | -47.89% |
52 Week High | 7.12 |
52 Week Low | 1.12 |
Spread (Intraday) | 0.02 (1.27%) |
Company Name | Predictive Oncology Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://predictive-oncology.com |
Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions